[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016 Coagulation Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

October 2015 | 455 pages | ID: 2AA54DE3B5EEN
Venture Planning Group

US$ 9,200.00 US$ 11,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500.

Summary

This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.

The report explores business and technological trends in the US coagulation testing market; provides leading supplier market shares estimates, as well as test volume forecasts for over 40 procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care center, surgery centers, nursing homes, and birth centers; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Strategic Recommendations
  • Product development and business expansion opportunities with significant market appeal.
  • 'Ideal' product models with tentative prices and operating characteristics.
  • Alternative market penetration strategies for instrument and reagent suppliers.
  • Potential market entry barriers and risks.
Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis

Sales and market shares of major instrument and reagent suppliers.

Market Segmentation Analysis
  • Comprehensive market segmentation analysis, including:
    • Centralized Testing
    • Hospitals
    • Commercial/Private Laboratories
    • POC/Decentralized Testing
    • Physician Offices/Group Practices
    • Emergency Rooms
    • Operating/Recovery Suites
    • ICUs/CCUs
    • Cancer Clinics
    • Ambulatory Care Centers
    • Surgery Centers
    • Nursing Homes
    • Birth Centers
  • Test volume forecasts for over 40 major procedures by market segment.
Current and Emerging Products
  • Review of established and emerging procedures.
  • Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
  • Analysis of current and emerging technologies and their potential market applications.
  • Comprehensive lists of companies developing or marketing new technologies and products by test.
Competitive Strategies
  • Extensive strategic profiles of major suppliers and emerging market entrants.
  • The companies analyzed in the report include:
    • Abbott
    • ADI/American Diagnostica
    • Axis-Shield
    • Alere/Biosite/Inverness
    • Beckman Coulter/Danaher
    • Becton Dickinson
    • Bio/Data Corporation
    • Chrono-Log
    • Corgenix Medical
    • Diagnostica Stago/Trinity Biotech
    • Grifols
    • Helena Laboratories
    • Hyphen BioMed
    • Instrumentation Laboratory
    • ITC/Nexus Dx
    • Roche
    • Siemens
    • Sienco
    • Sysmex
    • Thermo Fisher
    • ZyCare/Alere
Contains 455 pages and 60 tables
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Ethanol Flocculation Test
  8. Euglobulin Lysis
  9. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. Fibrin Degradation Products
  11. Fibrinogen
  12. Heparin
  13. Hirudin
  14. Hypercoagulability and Thrombosis
  15. Lipoprotein a
  16. Plasmin
  17. Plasminogen
  18. Plasminogen Activator Inhibitor (PAI)
  19. Platelet Function Tests
  20. Platelet Aggregation
  21. Proteins C and S
  22. Prothrombin Fragment 1.2
  23. Prothrombin Time (PT)
  24. Reptilase Time
  25. Thrombin Time
  26. Tissue-Type Plasminogen Activator (t-PA)
  27. Von Willebrand's Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
  4. Molecular Diagnostics
  5. Microcomputers
  6. Automation
  7. Robotics
  8. Artificial Intelligence
  9. Dry Chemistry
  10. Biosensors

III. U.S.A.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Rationale for Testing Decentralization
  1. Overview
  2. Regulatory Trends
  3. Economic Trends
  4. Demographic Trends
  5. Technological Trends
  6. Social Trends
  7. Quality of Care
  8. Defensive Medicine
  9. Quality Control Issues
E. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares

IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

V. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

VI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE STRATEGIES

Abbott
ADI/American Diagnostica
Axis-Shield
Alere/Biosite/Inverness
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category
U.S.A., Laboratories Performing Coagulation Tests By Market Segment
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Commercial/Private Laboratories Average Daily Test Volume
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment
U.S.A., All Market Segments Coagulation Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume
U.S.A., Commercial/Private Laboratories Coagulation Test Volume
U.S.A., Physician Offices/Group Practices Coagulation Test Volume
U.S.A., Coagulation Reagent Market By Market Segment
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Coagulation Test Volume Forecast
U.S.A., Hospital Emergency Departments Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital ICUs/CCUs Coagulation Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Coagulation Reagent and Instrument Sales Forecast
U.S.A., Cancer Clinics Major Coagulation Test Volume Forecast
U.S.A., Cancer Clinics Coagulation Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Coagulation Test Volume Forecast
U.S.A., Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Coagulation Test Volume Forecast
U.S.A., Surgery Centers Coagulation Reagent and Instrument Sales Forecast
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Coagulation Test Volume Forecast
U.S.A., Nursing Homes Coagulation Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Coagulation Test Volume Forecast
U.S.A., Birth Centers Coagulation Reagent and Instrument Sales Forecast
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
U.S.A., Coagulation Instrument Market By Market Segment
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
U.S.A., Total Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares


More Publications